Advantage Alpha Capital Partners LP Tg Therapeutics, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $419 Million
- Q3 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 22,379 shares of TGTX stock, worth $699,567. This represents 0.12% of its overall portfolio holdings.
Number of Shares
22,379
Previous 34,030
34.24%
Holding current value
$699,567
Previous $605,000
13.55%
% of portfolio
0.12%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
341Shares Held
87.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$356 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$284 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$112 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$100 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.54B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...